Pharmacy Medical News about Fever

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

A safety and feasibility study comparing an intermittent high dose with a daily standard dose of liposomal amphotericin B for persistent neutropenic fever
Journal of Medical Microbiology, 10/21/09

Ellis M et al. – This feasibility study suggests that a short intermittent high–dose course of 10/5/5 mg LAB kg–1 on days 1, 3 and 6 may be as safe and effective as a standard 14 day course of 3 mg kg–1 per day, with drug–acquisition cost savings and reduced drug exposure. A larger study is indicated for confirmation of this.

<< Previous
FDA Approves New Test to Aid in the Diagnosis of Rheumatoid...

Next >>
A Comparison of Gabapentin and Ketamine in Acute and Chronic Pain...

Management of fever in children: Summary of the Italian pediatric society guidelines
Clinical Therapeutics, 10/19/09 Relevance Score: 90%

Differentiating PFAPA Syndrome From Monogenic Periodic Fevers
Pediatrics, 10/01/09 Relevance Score: 90%

Periodic fever responds to vitamin B12 treatment
Rheumatology International, 10/02/09 Relevance Score: 89%

Managing Rocky Mountain spotted fever
Expert Review of Anti-infective Therapy, 11/12/09 Relevance Score: 88%

The “fever workup” and respiratory culture practice in critically ill trauma patients
Journal of Critical Care, 10/26/09 Relevance Score: 88%